These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12503407)

  • 1. Characteristics of clinical Acinetobacter spp. strains.
    Hostacká A; Klokocníková L
    Folia Microbiol (Praha); 2002; 47(5):579-82. PubMed ID: 12503407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and changing minimum inhibitory concentration (MIC) of Acinetobacter species from a tertiary care setup.
    Capoor MR; Nair D; Srivastava L; Gupta B; Aggarwal P
    J Commun Dis; 2005 Jun; 37(2):99-107. PubMed ID: 16749272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of virulence phenotypes and antibiotic resistance in clinical strains of Acinetobacter baumannii isolated in Nashville, Tennessee.
    Boone RL; Whitehead B; Avery TM; Lu J; Francis JD; Guevara MA; Moore RE; Chambers SA; Doster RS; Manning SD; Townsend SD; Dent L; Marshall D; Gaddy JA; Damo SM
    BMC Microbiol; 2021 Jan; 21(1):21. PubMed ID: 33422000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936).
    Henwood CJ; Gatward T; Warner M; James D; Stockdale MW; Spence RP; Towner KJ; Livermore DM; Woodford N
    J Antimicrob Chemother; 2002 Mar; 49(3):479-87. PubMed ID: 11864948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
    Zhao C; Xie W; Zhang W; Ye Z; Wu H
    Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acinetobacter in Denmark: I. Taxonomy, antibiotic susceptibility, and pathogenicity of 112 clinical strains.
    Gerner-Smidt P; Frederiksen W
    APMIS; 1993 Nov; 101(11):815-25. PubMed ID: 8286090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Problem of treatment for pyo-inflammatory complications caused by Acinetobacter].
    Bogomolova NS; Bol'shakov LV; Kuznetsova SM
    Anesteziol Reanimatol; 2014; (1):26-32. PubMed ID: 24749305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility of Acinetobacter calcoaceticus to antimicrobial drugs, alone and combined, with and without defibrinated human blood.
    Traub WH; Spohr M; Bauer D
    Chemotherapy; 1989; 35(2):95-104. PubMed ID: 2758872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility of clinical isolates of Acinetobacter baumannii.
    Shi ZY; Liu PY; Lau Y; Lin Y; Hu BS; Shir J-M
    Diagn Microbiol Infect Dis; 1996 Feb; 24(2):81-5. PubMed ID: 9147913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibiotic resistance profiles of Acinetobacter species isolated from several clinical samples between 2007-2010].
    Ozdem B; Gürelik FC; Celikbilek N; Balıkçı H; Açıkgöz ZC
    Mikrobiyol Bul; 2011 Jul; 45(3):526-34. PubMed ID: 21935786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and antimicrobial susceptibility of Acinetobacter spp. isolated from meat.
    Carvalheira A; Casquete R; Silva J; Teixeira P
    Int J Food Microbiol; 2017 Feb; 243():58-63. PubMed ID: 27992816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
    Keskin H; Tekeli A; Dolapci İ; Öcal D
    Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibiotic resistance of Acinetobacter baumannii isolates: data from Ibni Sina Hospital for the year 2002].
    Akan OA
    Mikrobiyol Bul; 2003 Oct; 37(4):241-6. PubMed ID: 14748260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activity of meropenem and comparators against Acinetobacter strains isolated from European hospitals, 1997-2000.
    Turner PJ; Greenhalgh JM;
    Clin Microbiol Infect; 2003 Jun; 9(6):563-7. PubMed ID: 12848736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evolution of antimicrobial susceptibility of Acinetobacter baumannii clinical isolates].
    López-Hernández S; Alarcón T; López-Brea M
    Rev Esp Quimioter; 2000 Dec; 13(4):394-400. PubMed ID: 11498706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility testing of Acinetobacter spp. by NCCLS broth microdilution and disk diffusion methods.
    Swenson JM; Killgore GE; Tenover FC
    J Clin Microbiol; 2004 Nov; 42(11):5102-8. PubMed ID: 15528702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characterization and determination of antibiotic resistance profiles of a single clone Acinetobacter baumannii strains isolated from blood cultures].
    Karagöz A; Baran I; Aksu N; Acar S; Durmaz R
    Mikrobiyol Bul; 2014 Oct; 48(4):566-76. PubMed ID: 25492652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. Isolated from patients at Tehran hospitals.
    Feizabadi MM; Fathollahzadeh B; Taherikalani M; Rasoolinejad M; Sadeghifard N; Aligholi M; Soroush S; Mohammadi-Yegane S
    Jpn J Infect Dis; 2008 Jul; 61(4):274-8. PubMed ID: 18653968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antimicrobial resistance and existence of metallo-beta-lactamase in Acinetobacter species isolated from adult patients].
    Eser OK; Ergin A; Hasçelik G
    Mikrobiyol Bul; 2009 Jul; 43(3):383-90. PubMed ID: 19795613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of synergistic activity of antibiotic combinations in extensive drug-resistant
    Abdel Halim RM; Saber SM; Fahim NAE
    J Med Microbiol; 2023 Feb; 72(2):. PubMed ID: 36762530
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.